Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Eloxx Pharmaceuticals Inc

ELOX
Current price
0.0003 USD +0.0001 USD (+50.00%)
Last closed 0.0002 USD
ISIN US29014R1032
Sector Healthcare
Industry Biotechnology
Exchange PINK
Capitalization 629 USD
Yield for 12 month -99.97 %
1Y
3Y
5Y
10Y
15Y
ELOX
21.11.2021 - 28.11.2021

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts. Address: 480 Arsenal Way, Watertown, MA, United States, 02472

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

30 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures ELOX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -19 238 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -73.24 %
PEG Ratio
Return On Equity TTM -615.23 %
Wall Street Target Price 30 USD
Revenue TTM
Book Value -6.53 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -8.88 USD
Diluted Eps TTM -8.88 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ELOX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ELOX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:40
Payout Ratio
Last Split Date 02.12.2022
Dividend Date 20.12.2017

Stock Valuation ELOX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.1017
Price Book MRQ 6.3127

Financials ELOX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ELOX

For 52 weeks

1.74 USD
50 Day MA 0.12 USD
Shares Short Prior Month 42 744
200 Day MA 0.64 USD
Short Ratio 0.66
Shares Short 21 485
Short Percent 0.8 %